a year ago

Amply Secures £1.4M in Grant Funding to Advance AI-Powered Drug Discovery

  • Amply, a Belfast-based biotech company, has secured £1.4 million in grant funding

  • The startup will use the investment to further develop its AI-powered drug discovery platform, which is being used to develop new RNAi therapy for Acute Myeloid Leukaemia and a new nebulised antimicrobial product for MDR-TB

  • The investment arrives in two tranches; £835,000 is provided by Innovate UK and Innosuisse, and £602,000 is provided by Innovate UK

  • Amply plans to raise an additional £1.4 million in a seed funding round in the second quarter of this year.

      • ProblemHealthcare

      "Developing new drugs is a slow and expensive process, often taking years and billions of dollars. This makes it difficult for smaller companies and researchers to compete with big pharma."

      Solution

      "Amply is using AI to accelerate drug discovery by leveraging the power of evolution to find new medicines from nature. Their platform will help researchers develop new treatments more quickly and efficiently, making them available to more people."

      Covered on